BioRap Technologies Ltd.

www.bio-rap.com

Technology Transfer Company

Ceased to Operate Q4/2024

Tech Verticals Preferences

Medical Devices, MedTech

General Data

Established	2001
Reg. Number:	abCDe

DESCRIPTION

BioRap Technologies Ltd. is a rapidly growing technology transfer company that is built upon the creative innovations and patented technologies developed by the research scientists of the Rappaport Family Institute for Research in the Biomedical Sciences at the Technion.
Its approach, which identifies commercial opportunities emanating from discovery research by leading scientists and advanced technologies has resulted, among many others, in the invention of Azilect (Rasagiline), an effective drug in the treatment of Parkinson’s Disease, currently marketed by Teva Pharmaceuticals world-wide.

BioRap provides a one-stop shop to advance the research and development of groundbreaking discoveries by fostering strategic collaborations with industry through licensing, sponsored research and new venture agreements.
It is dedicated to offering the market superior biomedical solutions for contemporary health care needs. The Rappaport Institute consistently introduces biotech concepts based on novel scientific insights and translation to critical human health care issues.

AFFILIATION

Account ID	Affiliation Type	Name	Parent Name	Status
		Technion - Israel Institute of Technology
	Accelerator	Technion T-Hub	Technion - Israel Institute of Technology
	Division	Rappaport Family Institute for Research in the Medical Sciences (cc)	Technion - Israel Institute of Technology
49605D8A-A8BA-EE11-B812-00505695CD29	Investment Arm	Technion Investment Opportunities Fund LP (TIOF)	Technion - Israel Institute of Technology
85A5DB50-207A-E111-AC59-00155D32A403	Investment Arm	T3 - Technion Technology Transfer - Technion R&D Foundation (TRDF) Ltd.	Technion - Israel Institute of Technology
FA72D3A3-493A-E311-8237-00237DE91982	Investment Arm	AMIT - Alfred Mann Institute at the Technion Ltd.	Technion - Israel Institute of Technology
A1A54AFB-E941-E611-BD22-80C16E7D3630	Spin-off	FeelIT Technologies Ltd.	Technion - Israel Institute of Technology
FAB15335-9980-E511-BD22-80C16E7D3630	Subsidiary	The Technion T-Factor	Technion - Israel Institute of Technology
90A5DB50-207A-E111-AC59-00155D32A403	Investment Arm	BioRap Technologies Ltd.	Rappaport Family Institute for Research in the Medical Sciences (cc)	Ceased
7186ACDD-1929-E411-A2AF-80C16E7D3630	Subsidiary	Technion's BizTec Program	Technion T-Hub

REMARKS

Date	Remark
	Expertise:
	- R&D in Drugs, Vaccines and Diagnostics of Cancer, Inflammatory, Renal and Autoimmune diseases, Diabetes, Stem Cells, Cardiovascular System.
	- Genetics and Proteomics.

CONTACT INFO

Expand / Collapse All

Main Address: Haifa, Israel

Address	1 Efron St.
POB	9697
City	Haifa
Country	Israel
Zip	3525422

Contact Person	abC Defghij
Contact E-Mail	abC Defghij
Company E-mail	abC Defghij
Telephone	abC Defghij
Fax	abC Defghij

Preferences

Stage Preferences

R&D,Seed

	PORTFOLIO COMPANIES

Exits (1)

Company Name		Exit Type	Date Announced	Amount	Remarks
abC Defghij		Acquired	19/07/2006	abCDe	In shares.

Historic Portfolio (7)

Company Name

Sector

Round/Deal Type

Date Announced

Investor Amount

Total Deal Amount

Remarks

EasyTrace

Ceased to Operate

Biomed

Seed

01/04/2004

N/A

Iluten

Ceased to Operate

Biomed

Seed

13/01/2010

N/A

$0.23m

Microrap

Ceased to Operate

Biomed

Seed

01/09/2007

N/A

$0.12m

Holds 15% of the company

MPT

Ceased to Operate

Biomed

Seed

01/06/2013

N/A

$0.6m

PlexiCure

Ceased to Operate

Biomed

Seed

01/12/2010

N/A

PRS Systems

Ceased to Operate

Biomed

Seed

01/01/2004

N/A

Vaccinogen

Ceased to Operate

Biomed

Seed

01/04/2001

N/A

Last Updated:	abCDe
IVC Number:	abCDe